GoHealth Research Development vs Net Income From Continuing Ops Analysis
GOCO Stock | USD 8.70 0.11 1.28% |
GoHealth financial indicator trend analysis is much more than just examining GoHealth latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether GoHealth is a good investment. Please check the relationship between GoHealth Research Development and its Net Income From Continuing Ops accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.
Research Development vs Net Income From Continuing Ops
Research Development vs Net Income From Continuing Ops Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of GoHealth Research Development account and Net Income From Continuing Ops. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between GoHealth's Research Development and Net Income From Continuing Ops is 0.43. Overlapping area represents the amount of variation of Research Development that can explain the historical movement of Net Income From Continuing Ops in the same time period over historical financial statements of GoHealth, assuming nothing else is changed. The correlation between historical values of GoHealth's Research Development and Net Income From Continuing Ops is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Research Development of GoHealth are associated (or correlated) with its Net Income From Continuing Ops. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Income From Continuing Ops has no effect on the direction of Research Development i.e., GoHealth's Research Development and Net Income From Continuing Ops go up and down completely randomly.
Correlation Coefficient | 0.43 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Research Development
Net Income From Continuing Ops
Most indicators from GoHealth's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into GoHealth current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.At this time, GoHealth's Selling General Administrative is very stable compared to the past year. As of the 15th of May 2024, Sales General And Administrative To Revenue is likely to grow to 0.20, while Tax Provision is likely to drop about 63.6 K.
2023 | 2024 (projected) | Depreciation And Amortization | 105.7M | 84.0M | Interest Income | 9.4M | 9.9M |
GoHealth fundamental ratios Correlations
Click cells to compare fundamentals
GoHealth Account Relationship Matchups
High Positive Relationship
High Negative Relationship
GoHealth fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.6B | 2.1B | 2.1B | 1.7B | 1.5B | 1.7B | |
Short Long Term Debt Total | 291.7M | 400.6M | 696.3M | 557.4M | 592.4M | 466.3M | |
Other Current Liab | 25.3M | 35.3M | 61.1M | 63.4M | 85.6M | 52.0M | |
Total Current Liabilities | 113.1M | 127.4M | 217.1M | 265.5M | 370.0M | 209.2M | |
Total Stockholder Equity | 860.1M | 378.8M | 353.1M | 318.1M | 231.0M | 358.3M | |
Other Liab | 340.9M | 185.8M | 274.4M | 259.0M | 233.1M | 214.6M | |
Net Tangible Assets | (309.2M) | (694.9M) | (241.6M) | (182.6M) | (209.9M) | (220.4M) | |
Property Plant And Equipment Net | 6.3M | 17.4M | 47.7M | 46.8M | 48.8M | 32.8M | |
Current Deferred Revenue | 15.2M | 736K | 536K | 50.6M | 67.2M | 70.6M | |
Net Debt | 279.4M | 256.3M | 611.9M | 541.0M | 501.5M | 402.4M | |
Retained Earnings | (312.6M) | (18.8M) | (208.3M) | (357.0M) | (420.3M) | (399.3M) | |
Accounts Payable | 69.6M | 87.2M | 144.0M | 137.2M | 136.4M | 110.6M | |
Cash | 12.3M | 144.2M | 84.4M | 16.5M | 90.8M | 63.9M | |
Non Current Assets Total | 1.5B | 1.7B | 1.6B | 1.2B | 1.0B | 1.3B | |
Non Currrent Assets Other | 282.9M | 624.3M | 997.5M | 697.4M | 577.7M | 597.1M | |
Other Assets | 282.9M | 624.3M | 997.5M | 697.4M | 802.0M | 589.4M | |
Cash And Short Term Investments | 12.3M | 144.2M | 84.4M | 16.5M | 90.8M | 63.9M | |
Net Receivables | 125.5M | 218.4M | 285.9M | 340.5M | 911.9M | 957.5M | |
Common Stock Shares Outstanding | 5.6M | 5.6M | 7.1M | 8.4M | 9.3M | 7.6M | |
Long Term Debt Total | 288.7M | 396.4M | 665.1M | 504.8M | 580.5M | 408.1M | |
Liabilities And Stockholders Equity | 1.6B | 2.1B | 2.1B | 1.7B | 1.5B | 1.7B | |
Non Current Liabilities Total | 629.1M | 582.3M | 959.3M | 802.1M | 674.6M | 720.3M | |
Capital Lease Obligations | 421K | 396.4M | 25.9M | 47.3M | 45.3M | 68.7M | |
Other Current Assets | 6.0M | 29.2M | 58.7M | 57.6M | (1.0B) | (952.6M) | |
Other Stockholder Equity | 312.6M | 397.5M | 561.4M | 625.9M | 602.1M | 461.9M | |
Total Liab | 742.2M | 709.6M | 1.2B | 1.1B | 1.1B | 938.5M | |
Net Invested Capital | 603.8M | 781.0M | 1.0B | 778.8M | 728.7M | 684.6M | |
Total Current Assets | 143.8M | 391.8M | 429.0M | 414.6M | 476.4M | 350.1M | |
Accumulated Other Comprehensive Income | (17K) | (18.8M) | (208.4M) | (144K) | (127K) | (133.4K) | |
Non Current Liabilities Other | 242.7M | 3.3M | 294.2M | 297.3M | 9.1M | 8.6M | |
Net Working Capital | 30.7M | 264.5M | 211.9M | 149.1M | 106.4M | 140.9M | |
Short Term Debt | 3M | 4.2M | 11.4M | 14.2M | 80.8M | 84.8M | |
Property Plant Equipment | 6.3M | 17.4M | 47.7M | 46.8M | 53.8M | 28.6M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in GoHealth. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in GoHealth Stock, please use our How to Invest in GoHealth guide.Note that the GoHealth information on this page should be used as a complementary analysis to other GoHealth's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for GoHealth Stock analysis
When running GoHealth's price analysis, check to measure GoHealth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GoHealth is operating at the current time. Most of GoHealth's value examination focuses on studying past and present price action to predict the probability of GoHealth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GoHealth's price. Additionally, you may evaluate how the addition of GoHealth to your portfolios can decrease your overall portfolio volatility.
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |
Is GoHealth's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GoHealth. If investors know GoHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GoHealth listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.241 | Earnings Share (7.19) | Revenue Per Share 77.759 | Quarterly Revenue Growth 0.013 | Return On Assets (0.03) |
The market value of GoHealth is measured differently than its book value, which is the value of GoHealth that is recorded on the company's balance sheet. Investors also form their own opinion of GoHealth's value that differs from its market value or its book value, called intrinsic value, which is GoHealth's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GoHealth's market value can be influenced by many factors that don't directly affect GoHealth's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GoHealth's value and its price as these two are different measures arrived at by different means. Investors typically determine if GoHealth is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GoHealth's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.